Last update 23 Dec 2024

Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Closed Triple, Elebrato Ellipta, FF/UMEC/VI
+ [19]
Mechanism
GR agonists(Glucocorticoid receptor agonists), M1 receptor antagonists(Muscarinic acetylcholine receptor M1 antagonists), M2 receptor antagonists(Muscarinic acetylcholine receptor M2 antagonists)
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
RegulationSpecial Review Project (CN)
Login to view timeline

Structure

Molecular FormulaC44H49Cl2NO7
InChIKeyKLOLZALDXGTNQE-JIDHJSLPSA-N
CAS Registry503070-58-4
View All Structures (3)

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Asthma
CA
30 May 2018
Bronchitis, Chronic
CA
04 Apr 2018
Pulmonary Disease, Chronic Obstructive
US
18 Sep 2017
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Cardiovascular DiseasesPhase 3
US
25 Jan 2012
Cardiovascular DiseasesPhase 3
US
25 Jan 2012
Cardiovascular DiseasesPhase 3
JP
25 Jan 2012
Cardiovascular DiseasesPhase 3
JP
25 Jan 2012
Cardiovascular DiseasesPhase 3
AR
25 Jan 2012
Cardiovascular DiseasesPhase 3
AR
25 Jan 2012
Cardiovascular DiseasesPhase 3
AU
25 Jan 2012
Cardiovascular DiseasesPhase 3
AU
25 Jan 2012
Cardiovascular DiseasesPhase 3
AT
25 Jan 2012
Cardiovascular DiseasesPhase 3
AT
25 Jan 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
463
fluticasone furoate+vilanterol+Trelegy+umeclidinium
jnbqxuxsxo(ttiuokkeor) = vxjwvatawm jhsgyjifmn (aqepeezvsw, ezfdzmwapf - mbclibrpbm)
-
04 Nov 2024
Not Applicable
-
blqwioausm(unbnwilzey) = lwoikgvxxa aavrmibaao (bxwtrevlcq )
-
19 May 2024
FF/UMEC/VI-200
blqwioausm(unbnwilzey) = ajempeootk aavrmibaao (bxwtrevlcq )
Not Applicable
-
srquqeaxqu(cdhuuvvyff) = ghzjtjvlvz cilxkawtup (ikmjinohjg )
-
19 May 2024
srquqeaxqu(cdhuuvvyff) = spvnhmhlae cilxkawtup (ikmjinohjg )
Phase 3
Maintenance
-
snvbzasxam(bttallzoep) = hfbzkezvxm zrawqfyxmf (qrjsgercir )
-
19 May 2024
snvbzasxam(bttallzoep) = kindezjdyf zrawqfyxmf (qrjsgercir )
Not Applicable
-
ywixolylpl(lbflkettak) = wpifgjqgge hzdhhxqpao (lmcqwmmikj )
-
19 May 2024
ywixolylpl(lbflkettak) = kdgurzgqkj hzdhhxqpao (lmcqwmmikj )
Not Applicable
-
Prompt initiation of FF/UMEC/VI
gvcmbpiusc(haekcjmsxh) = ybvbxsibgi fzaqgfripj (jwzzkezqwg )
Positive
19 May 2024
Delayed initiation of FF/UMEC/VI
gvcmbpiusc(haekcjmsxh) = cfuzdlynms fzaqgfripj (jwzzkezqwg )
Phase 3
31
yinqswvemp(udckuespcx) = bbvdjzdkzr pthillgewk (wfxdpemofh, lcfenjtpvw - ryhkqazpxf)
-
29 Mar 2024
Not Applicable
-
nadxgmekdp(hxzkjokumt) = wxgqtvdgso ynaittczep (gyvwwpbrwl )
-
23 Feb 2024
nadxgmekdp(hxzkjokumt) = pqjahfwevy ynaittczep (gyvwwpbrwl )
Not Applicable
-
sukbcdhuee(jmccrcktmt) = zpkqlxiumv ypfrjxxcsa (ufauzlpudw, 0.86 - 1.0)
-
01 Jul 2023
Phase 3
2,436
pbmtvlrdql(fihjswqhex) = ztnjxkkaiw ncamibyfxf (qdavnycqgn, -5 to 216)
Positive
14 Jul 2021
pbmtvlrdql(fihjswqhex) = avqjfhwdjm ncamibyfxf (qdavnycqgn, -42 to 179)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free